MyAverix Finance
TA · Healthcare
Canzon Israel Ltd (CNZN)
Drug Manufacturers - Specialty & Generic
Canzon Israel Ltd (CNZN) is listed on TA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CNZN
Canzon Israel Ltd (CNZN) — FAQ
What is CNZN's P/E ratio?
The price-to-earnings (P/E) ratio for Canzon Israel Ltd (CNZN) is 18.00 (data as of 2026-05-24).
Does Canzon Israel Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Canzon Israel Ltd (CNZN). Check the MyAverix Finance app for the latest dividend data.
What sector is Canzon Israel Ltd in?
Canzon Israel Ltd (CNZN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CNZN listed on?
CNZN is listed on TA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.